Shao-Liang Chen -PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)

Shao-Liang Chen, Nanjing First Hospital, Nanjing Medical University, China
PADN-5: Pulmonary arterial denervation in patients with pulmonary hypertension associated with left heart failure (NCT02220335)
Sponsor: Nanjing Healthy Bureau & National Science Foundation of China

About the author

Shao-Liang Chen

MD, PhD

Nanjing First Hospital, Nanjing Medical University

China

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

About the author

Shao-Liang Chen

Related Content

{{GlobalController.truncateTitle("Keynote lecture session 2021", 65)}}

{{GlobalController.truncateTitle("John Scandurra & Irene Lang - Implantable devices to improve pulmonary circulation compliance", 65)}}

{{GlobalController.truncateTitle("Kelly Chin - Efﬁcacy and safety of initial triple oral versus initial double oral combination therapy in patients with newly diagnosed pulmonary arterial hypertension: Results of the randomised controlled TRITON study (NCT02558231)", 65)}}

{{GlobalController.truncateTitle("Ronald Oudiz - ABI-009, an mToR Inhibitor, for patients with severe pulmonary arterial hypertension (NCT02587325)", 65)}}

{{GlobalController.truncateTitle("Erika Rosenzweig - A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: early experience in adolescents and adults", 65)}}

Add to reading list

Share this content

Our research platform is the world.